Literature DB >> 9891073

A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation.

D Besser1, J F Bromberg, J E Darnell, H Hanafusa.   

Abstract

The receptor tyrosine kinase Eyk, a member of the Axl/Tyro3 subfamily, activates the STAT pathway and transforms cells when constitutively activated. Here, we compared the potentials of the intracellular domains of Eyk molecules derived from c-Eyk and v-Eyk to transform rat 3Y1 fibroblasts. The v-Eyk molecule induced higher numbers of transformants in soft agar and stronger activation of Stat3; levels of Stat1 activation by the two Eyk molecules were similar. A mutation in the sequence Y933VPL, present in c-Eyk, to the v-Eyk sequence Y933VPQ led to increased activation of Stat3 and increased transformation efficiency. However, altering another sequence, Y862VNT, present in both Eyk molecules to F862VNT markedly decreased transformation without impairing Stat3 activation. These results indicate that activation of Stat3 enhances transformation efficiency and cooperates with another pathway to induce transformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9891073      PMCID: PMC116068          DOI: 10.1128/MCB.19.2.1401

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

Authors:  E J Lowenstein; R J Daly; A G Batzer; W Li; B Margolis; R Lammers; A Ullrich; E Y Skolnik; D Bar-Sagi; J Schlessinger
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Rat cell line 3y1 and its virogenic polyoma- and sv40- transformed derivatives.

Authors:  G Kimura; A Itagaki; J Summers
Journal:  Int J Cancer       Date:  1975-04-15       Impact factor: 7.396

3.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.

Authors:  J Y Wang
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

4.  Involvement of p21ras in activation of extracellular signal-regulated kinase 2.

Authors:  A M de Vries-Smits; B M Burgering; S J Leevers; C J Marshall; J L Bos
Journal:  Nature       Date:  1992-06-18       Impact factor: 49.962

5.  The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter.

Authors:  B J Wagner; T E Hayes; C J Hoban; B H Cochran
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

6.  A novel oncogene, v-ryk, encoding a truncated receptor tyrosine kinase is transduced into the RPL30 virus without loss of viral sequences.

Authors:  R Jia; B J Mayer; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Activation of c-Src in cells bearing v-Crk and its suppression by Csk.

Authors:  H Sabe; M Okada; H Nakagawa; H Hanafusa
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

8.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.

Authors:  J P O'Bryan; R A Frye; P C Cogswell; A Neubauer; B Kitch; C Prokop; R Espinosa; M M Le Beau; H S Earp; E T Liu
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

9.  The murine ufo receptor: molecular cloning, chromosomal localization and in situ expression analysis.

Authors:  M Faust; C Ebensperger; A S Schulz; L Schleithoff; H Hameister; C R Bartram; J W Janssen
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

10.  A novel putative tyrosine kinase receptor with oncogenic potential.

Authors:  J W Janssen; A S Schulz; A C Steenvoorden; M Schmidberger; S Strehl; P F Ambros; C R Bartram
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

View more
  45 in total

1.  DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

Authors:  Thomas Meyer; Andreas Marg; Petra Lemke; Burkhard Wiesner; Uwe Vinkemeier
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

2.  Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity.

Authors:  Hung-Ching Hsia; Jessica E Hutti; Albert S Baldwin
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

3.  Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.

Authors:  Y T Tsai; Y H Su; S S Fang; T N Huang; Y Qiu; Y S Jou; H M Shih; H J Kung; R H Chen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Rac1 mediates STAT3 activation by autocrine IL-6.

Authors:  T R Faruqi; D Gomez; X R Bustelo; D Bar-Sagi; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.

Authors:  T Bowman; M A Broome; D Sinibaldi; W Wharton; W J Pledger; J M Sedivy; R Irby; T Yeatman; S A Courtneidge; R Jove
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

6.  Simian varicella virus inhibits the interferon gamma signalling pathway.

Authors:  Werner J D Ouwendijk; Suzanne van Veen; Ravi Mahalingam; Georges M G M Verjans
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

7.  Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium.

Authors:  Rong Wu; Shishinn Sun; Bettie M Steinberg
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

8.  Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.

Authors:  S E Wheeler; S Suzuki; S M Thomas; M Sen; R J Leeman-Neill; S I Chiosea; C-T Kuan; D D Bigner; W E Gooding; S Y Lai; J R Grandis
Journal:  Oncogene       Date:  2010-07-12       Impact factor: 9.867

9.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

Authors:  P K Epling-Burnette; J H Liu; R Catlett-Falcone; J Turkson; M Oshiro; R Kothapalli; Y Li; J M Wang; H F Yang-Yen; J Karras; R Jove; T P Loughran
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

10.  Chondromodulin-1 directly suppresses growth of human cancer cells.

Authors:  Hisashi Mera; Hiroyuki Kawashima; Tatsuya Yoshizawa; Osamu Ishibashi; Md Moksed Ali; Tadashi Hayami; Hiroshi Kitahara; Hiroshi Yamagiwa; Naoki Kondo; Akira Ogose; Naoto Endo; Hiroyuki Kawashima
Journal:  BMC Cancer       Date:  2009-05-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.